Kaigene Signs Exclusive Licensing Deal with Celltrion for Antibody Therapy
November 4, 2025
Kaigene Inc., a biotechnology company based in the United States and focused on developing next-generation antibody therapies for autoimmune disorders, has announced an exclusive global